Current Report Filing (8-k)
08 December 2021 - 10:02PM
Edgar (US Regulatory)
0000934549
false
0000934549
2021-12-06
2021-12-06
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
December 6, 2021
ACACIA
RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
|
|
001-37721
|
|
95-4405754
|
(State or other jurisdiction of
|
|
(Commission
|
|
(I.R.S. Employer
|
incorporation)
|
|
File Number)
|
|
Identification No.)
|
767
Third Avenue, Suite
602
|
|
|
New York, NY
|
|
10017
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(Registrant’s telephone number, including
area code): (949) 480-8300
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
Common Stock, par value $0.001 per share
|
ACTG
|
The NASDAQ Stock Market, LLC
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). o Emerging
growth company
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. o
On December 6, 2021, the Board of Directors (the
“Board”) of Acacia Research Corporation (the “Company”) approved a stock repurchase program authorizing the Company
to purchase up to an aggregate of $15 million of the Company’s common stock in accordance with Rule 10b-18 of the Securities Exchange
Act of 1934, as amended. The shares may be purchased through open market purchases, block trades, 10b5-1 plans, or by means of private
purchases, from time to time, through December 6, 2022. Purchases will be at times and in amounts as management deems appropriate, subject
to approval by the Strategic Committee of the Board, based on factors such as market conditions, legal requirements and other business
considerations.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: December 7, 2021
|
|
|
ACACIA RESEARCH CORPORATION
|
|
|
|
By:
|
/s/
Clifford Press
|
|
Name:
|
Clifford Press
|
|
Title:
|
Chief Executive Officer
|
Acacia Research Technolo... (NASDAQ:ACTG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Acacia Research Technolo... (NASDAQ:ACTG)
Historical Stock Chart
From Apr 2023 to Apr 2024